首页> Cancer drug resistance (Alhambra, Calif.)> Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways.

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maristella,Bungaro

第一单位： Medical Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin 10043, Italy.

作者： Maristella,Bungaro ^[1] ; Consuelo,Buttigliero ^[1] ; Marcello,Tucci ^[2]

作者单位： Medical Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin 10043, Italy. ^[1] Medical Oncology, Cardinal Massaia Hospital, Asti 14100, Italy. ^[2]

关键词 abiraterone androgen receptor signalling castration-resistant prostate cancer enzalutamide hormonal treatment resistance mechanisms

DOI 10.20517/cdr.2020.42

PMID 35582226

发布时间 2024-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer drug resistance (Alhambra, Calif.)

2020年3卷4期

726-741页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer drug resistance (Alhambra, Calif.)

2020年3卷4期

726-741页

检索历史清除

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways.

Cancer drug resistance (Alhambra, Calif.)

相似文献

同项目论文

Cancer drug resistance (Alhambra, Calif.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways.

Cancer drug resistance (Alhambra, Calif.)

相似文献

同项目论文

Cancer drug resistance (Alhambra, Calif.)

相关期刊

检索历史清除